Shares of Ambu A/S Unsponsored ADR (OTCMKTS:AMBBY - Get Free Report) gapped down before the market opened on Wednesday . The stock had previously closed at $11.00, but opened at $9.70. Ambu A/S shares last traded at $9.70, with a volume of 500 shares traded.
Ambu A/S Stock Performance
The firm has a 50 day moving average of $10.96 and a two-hundred day moving average of $12.83. The stock has a market cap of $2.35 billion, a PE ratio of 32.19 and a beta of 1.06. The company has a debt-to-equity ratio of 0.08, a current ratio of 2.86 and a quick ratio of 1.67.
Ambu A/S (OTCMKTS:AMBBY - Get Free Report) last posted its earnings results on Wednesday, May 6th. The company reported $0.07 earnings per share for the quarter. Ambu A/S had a return on equity of 9.15% and a net margin of 8.86%.
Ambu A/S Company Profile
(
Get Free Report)
Ambu A/S is a Denmark-based medical device company specializing in single-use diagnostic and life-supporting equipment for hospitals, clinics and emergency services. The company's core focus lies in developing products that enhance patient safety, streamline clinical workflows and reduce the risk of cross-contamination. Ambu's offerings span critical care solutions such as anesthesia and respiratory care devices, as well as advanced endoscopy systems for minimally invasive diagnostics and therapies.
Within its anesthesia and respiratory care segment, Ambu is known for its market-leading disposable resuscitators—commonly referred to as “Ambu bags”—as well as a range of airway management products, including laryngeal masks and endotracheal tubes.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Ambu A/S, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ambu A/S wasn't on the list.
While Ambu A/S currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.